These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24694385)

  • 1. Short-term continuous-flow ventricular assist devices.
    Takayama H; Takeda K; Doshi D; Jorde UP
    Curr Opin Cardiol; 2014 May; 29(3):266-74. PubMed ID: 24694385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridge to durable left ventricular assist device for refractory cardiogenic shock.
    Yoshioka D; Takayama H; Garan AR; Topkara VK; Han J; Li B; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K
    J Thorac Cardiovasc Surg; 2017 Apr; 153(4):752-762.e5. PubMed ID: 27988030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock.
    Windecker S
    Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical variability within the INTERMACS 1 profile: implications for treatment options.
    Dutt DP; Pinney SP
    Curr Opin Cardiol; 2014 May; 29(3):244-9. PubMed ID: 24694386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsatile left ventricular assist devices: what is the role in the modern era?
    Atluri P; Acker MA
    Semin Thorac Cardiovasc Surg; 2010; 22(2):106-8. PubMed ID: 21092883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of pediatric patients supported with continuous-flow ventricular assist devices: A report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS).
    Rossano JW; Lorts A; VanderPluym CJ; Jeewa A; Guleserian KJ; Bleiweis MS; Reinhartz O; Blume ED; Rosenthal DN; Naftel DC; Cantor RS; Kirklin JK
    J Heart Lung Transplant; 2016 May; 35(5):585-90. PubMed ID: 27056612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Implantation of a Left Ventricular Assist Device in Patients With Critical or Impending Cardiogenic Shock an Absolute Contraindication? Looking Back at Our Past Experience Trying to Identify Contraindicative Risk Factors.
    Dell'Aquila AM; Schneider SR; Risso P; Welp H; Glockner DG; Alles S; Sindermann JR; Scherer M
    Artif Organs; 2015 Dec; 39(12):998-1004. PubMed ID: 26011007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical considerations of percutaneous ventricular assist devices.
    Weiss SA; Jolly N
    J Invasive Cardiol; 2012 Jan; 24(1):25-31. PubMed ID: 22210586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assist devices for circulatory support in therapy-refractory acute heart failure.
    Koerner MM; Jahanyar J
    Curr Opin Cardiol; 2008 Jul; 23(4):399-406. PubMed ID: 18520726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical circulatory support in cardiogenic shock.
    Werdan K; Gielen S; Ebelt H; Hochman JS
    Eur Heart J; 2014 Jan; 35(3):156-67. PubMed ID: 24014384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: design and rationale of the ROADMAP clinical trial.
    Rogers JG; Boyle AJ; O'Connell JB; Horstmanshof DA; Haas DC; Slaughter MS; Park SJ; Farrar DJ; Starling RC
    Am Heart J; 2015 Feb; 169(2):205-210.e20. PubMed ID: 25641529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A continuous-flow external ventricular assist device for cardiogenic shock: Evolution over 10 years.
    Ando M; Garan AR; Takayama H; Topkara VK; Han J; Kurlansky P; Yuzefpolskaya M; Farr MA; Colombo PC; Naka Y; Takeda K
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):157-165.e1. PubMed ID: 29510941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term mechanical circulatory support by veno-arterial extracorporeal membrane oxygenation in the management of cardiogenic shock and end-stage heart failure.
    Brugts JJ; Caliskan K
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):145-53. PubMed ID: 24417434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INTERMACS: interval analysis of registry data.
    Holman WL; Pae WE; Teutenberg JJ; Acker MA; Naftel DC; Sun BC; Milano CA; Kirklin JK
    J Am Coll Surg; 2009 May; 208(5):755-61; discussion 761-2. PubMed ID: 19476831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Door-to-VAD time: an expedient management strategy for cardiogenic shock.
    Cabuay B; Hryniewicz K; Sun B; Feldman D
    Curr Opin Cardiol; 2010 May; 25(3):249-52. PubMed ID: 22393564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post myocardial infarction cardiogenic shock: a review of current therapies.
    Ng R; Yeghiazarians Y
    J Intensive Care Med; 2013; 28(3):151-65. PubMed ID: 21747126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.